Tablet Coatings Market: By Polymer Type, Others), By Functionality Coatings, Taste-Masking Coatings, Moisture Barrier Coatings, Others), By End User, Others) and Region Forecast 2020-2031
Tablet Coatings Market size was valued at US$ 2,559.1 million in 2024 and is expected to reach US$ 4,443.0 million by 2031, growing at a significant CAGR of 8.2% from 2025-2031. Moreover, the U.S. Tablet Coatings Market is projected to grow at 7.8% over the forecast period. The market encompasses the development, manufacturing, and application of coating materials used on pharmaceutical tablets. These coatings serve various functions such as protecting the tablet’s core from environmental conditions, masking unpleasant taste or odor, enhancing appearance, controlling drug release profiles, and improving patient compliance. Common types include film coatings, sugar coatings, and enteric coatings, each tailored to meet specific therapeutic and functional requirements.
The market is witnessing consistent growth driven by the expanding pharmaceutical and nutraceutical sectors. Innovations in drug delivery systems and increased demand for controlled-release formulations are fueling the need for advanced coating technologies. Rising health awareness and regulatory emphasis on product quality and safety are encouraging manufacturers to invest in functional and aesthetic coatings. With growing R&D investments and increasing generic drug production, especially in emerging economies, the market is projected to expand significantly in the coming years.
Based on the polymer type:
Among the polymer types, cellulosic polymers are anticipated to lead the market due to their superior film-forming properties, versatility, and regulatory acceptance. These polymers, particularly hydroxypropyl methylcellulose (HPMC), are widely used in both immediate-release and controlled-release formulations. Their ability to provide consistent coating performance, ease of processing, and excellent compatibility with active pharmaceutical ingredients (APIs) make them a preferred choice for pharmaceutical manufacturers globally.
Moreover, cellulosic polymers are derived from plant-based sources, aligning with the growing trend toward natural and sustainable ingredients. Their dominance is further supported by their widespread use across generics and branded drugs alike, enhancing market penetration.
Based on the functionality:
Based on functionality, immediate-release coatings are anticipated to dominate the market due to their extensive use in both over-the-counter (OTC) and prescription medications. These coatings are designed to disintegrate quickly upon ingestion, allowing for rapid drug absorption and fast onset of action an essential feature for pain relievers, antipyretics, and common cold medications. Their cost-effectiveness, ease of formulation, and compatibility with a wide range of active pharmaceutical ingredients contribute to their widespread adoption.
Additionally, as patient preference shifts toward fast-acting drugs and pharmaceutical companies aim for quicker therapeutic effects, the demand for immediate-release coatings continues to strengthen across global markets.
Based on the end user:
Based on end user, the pharmaceutical industry is expected to hold the largest share in the market. This dominance is driven by the high volume of prescription drug production, increasing demand for advanced drug delivery systems, and stringent quality standards requiring functional coatings for stability, release control, and patient compliance. Pharmaceutical companies heavily rely on coating technologies to differentiate products, improve shelf life, and meet regulatory requirements. With the growing prevalence of chronic diseases and rising global drug consumption, especially in aging populations, the need for coated tablets in the pharmaceutical sector continues to surge, reinforcing its leading market position.
Study Period
2025-2031Base Year
2024CAGR
8.2%Largest Market
Asia-PacificFastest Growing Market
Latin America
One of the most significant drivers propelling the market is the increased demand for controlled-release drug formulations. These formulations are designed to release active pharmaceutical ingredients (APIs) at a specific rate over a predetermined period, thereby enhancing therapeutic efficacy and reducing dosing frequency. Coatings play a critical role in these systems by enabling sustained, delayed, or targeted drug release.
This demand is particularly pronounced in the treatment of chronic conditions such as hypertension, diabetes, and psychiatric disorders, where patient adherence is vital. Tablet coatings allow for better control over drug pharmacokinetics and improve the stability of active ingredients. Pharmaceutical companies are increasingly investing in novel polymer-based coatings that provide reliable release profiles, even in challenging gastrointestinal conditions. As healthcare providers focus on improving patient-centric care and reducing side effects, the preference for advanced coatings continues to grow. This shift supports the robust expansion of the market.
A major challenge restricting the growth of the market is the stringent regulatory environment governing pharmaceutical products. Regulatory bodies such as the U.S. FDA, EMA, and WHO impose rigorous guidelines on excipient usage, manufacturing practices, and safety testing for coated tablets. Compliance with these standards requires extensive documentation, stability testing, and validation processes, which increase the time and cost of product development.
Smaller pharmaceutical companies and contract manufacturers often struggle to keep pace with evolving regulatory frameworks, particularly when introducing novel coating materials or technologies. Moreover, any variation in coating thickness, composition, or dissolution behaviour can lead to batch rejection, costly recalls, or delays in product launches. These complexities discourage rapid innovation and create barriers for market entry. While regulatory oversight ensures product safety and efficacy, it simultaneously acts as a bottleneck that slows market agility and responsiveness to evolving therapeutic needs.
The market holds substantial growth potential in emerging markets, particularly in Asia-Pacific, Latin America, and parts of Africa. These regions are experiencing rapid urbanization, rising healthcare expenditures, and greater access to medical services, leading to a surge in pharmaceutical consumption. In addition, governments are increasingly encouraging the production and use of cost-effective generic drugs to expand treatment accessibility. Tablet coatings enhance the shelf life, appearance, and patient acceptability of generics, making them more competitive in crowded markets.
Countries such as India and China have become key hubs for generic manufacturing, prompting coating material suppliers to expand operations and establish partnerships in these regions. The increasing demand for paediatric and geriatric formulations often requiring specialized coatings for taste masking or easy swallowing also contributes to this opportunity. As multinational pharmaceutical firms invest in local production capabilities, the demand for reliable and cost-efficient coating technologies in emerging markets is expected to escalate.
A growing trend in the market is the shift toward natural and non-synthetic coating materials, driven by increased consumer and regulatory demand for cleaner, safer, and more sustainable pharmaceutical ingredients. Traditional coatings often contain synthetic polymers, plasticizers, and colorants that may raise concerns regarding toxicity, allergens, or environmental impact. As a response, manufacturers are exploring natural polymers such as cellulose derivatives, starches, and gums to develop film coatings that are biodegradable, non-toxic, and suitable for vegan or allergen-free labelling.
This trend is further reinforced by the clean-label movement in nutraceuticals and over-the-counter (OTC) products, where consumers are scrutinizing inactive ingredients. Companies are also focusing on water-based and solvent-free coating processes to align with green chemistry principles and reduce manufacturing hazards. As sustainability becomes a strategic priority, the adoption of eco-friendly coating solutions is expected to reshape the innovation landscape in the market.
Largest Share of the Region: Asia-Pacific is projected to witness the fastest growth in the market over the forecast period. Countries such as China, India, South Korea, and Japan are leading the regional momentum, fuelled by rapidly expanding pharmaceutical manufacturing capabilities, rising healthcare investments, and strong domestic consumption of medicines. According to the India Brand Equity Foundation (IBEF), India alone accounts for over 20% of global generic drug exports and has more than 3,000 pharmaceutical companies and 10,000 manufacturing units. This thriving generic market demands efficient, cost-effective coating solutions to enhance product competitiveness.
Additionally, favourable government policies, such as India’s Production Linked Incentive (PLI) scheme and China’s focus on self-reliance in pharmaceutical production, are driving the adoption of advanced manufacturing technologies including tablet coatings. The increasing prevalence of chronic diseases and growing health awareness among populations further amplify the need for high-quality, coated drug formulations, making Asia-Pacific the leading growth engine in the global market.
Fastest Growing/ Emerging Region: Latin America is emerging as a promising region in the market, supported by improving healthcare infrastructure, rising demand for affordable medications, and growing investments from international pharmaceutical companies. Countries such as Brazil, Mexico, and Argentina are experiencing an uptick in local drug production, boosted by supportive regulations and public healthcare expansion. According to the Pan American Health Organization, pharmaceutical spending in the region has steadily increased, with Brazil alone accounting for over USD 30 billion in annual sales. A notable driver in the region is the increaseds demand for paediatric and geriatric formulations, where taste-masking and easy-to-swallow coatings are essential.
Moreover, trends toward natural ingredients and clean-label formulations are gradually taking hold, particularly in consumer health and nutraceutical segments. As multinational players establish partnerships with regional manufacturers and invest in technology transfer, Latin America is expected to evolve into a key growth frontier for the tablet coatings industry in the years ahead.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2025-2031 |
|
Market Size in 2024 |
US$ 2,559.1 million |
|
Market Size in 2031 |
US$ 4,443.0 million |
|
Market CAGR |
8.2% |
|
By Polymer Type |
|
|
By Functionality |
|
|
By End User |
|
|
By Region |
|
PBI Analysts anticipate that the market is experiencing steady growth, driven by rising pharmaceutical production, increased demand for controlled and immediate-release formulations, and advancements in coating technologies. Manufacturers are focusing on improving drug stability, masking unpleasant tastes, and enhancing patient compliance through innovative coating solutions. The dominance of cellulosic polymers and immediate-release coatings reflects the market's preference for versatile, cost-effective options. Asia-Pacific is emerging as the fastest-growing region due to expanding generic drug manufacturing and favorable regulatory support. With increasing health awareness and the rise in chronic diseases, the global demand for high-quality coated tablets is expected to grow significantly in the coming years.
Download Free Sample Report
The tablet coatings market size was valued at US$ 2,559.1 million in 2024 and is projected to grow at a significant CAGR of 8.2% from 2025-2031.
Cellulosic polymers, particularly hydroxypropyl methylcellulose (HPMC), are the most widely used due to their excellent film-forming properties, safety profile, and versatility across different drug formulations.
Key drivers include the increasing demand for controlled and immediate-release formulations, growing pharmaceutical production, rising health awareness, and advancements in coating materials and technologies.
Asia-Pacific is anticipated to be the fastest-growing region, driven by expanding generic drug manufacturing, supportive government policies, and a growing patient population.
Functionality determines the drug release profile and patient experience. For example, immediate-release coatings ensure fast action, while enteric coatings protect drugs from stomach acid and target release in the intestine.
| 1.Executive Summary |
| 2.Global Tablet Coatings Market Introduction |
| 2.1.Global Tablet Coatings Market - Taxonomy |
| 2.2.Global Tablet Coatings Market - Definitions |
| 2.2.1.Polymer Type |
| 2.2.2.Functionality |
| 2.2.3.End User |
| 2.2.4.Region |
| 3.Global Tablet Coatings Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Tablet Coatings Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Tablet Coatings Market By Polymer Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 5.1. Cellulosic Polymers |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Vinyl Derivatives |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Methacrylic Polymers |
| 5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Polyethylene Glycol (PEG) |
| 5.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Others |
| 5.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 6.Global Tablet Coatings Market By Functionality, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 6.1. Immediate-Release Coatings |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Sustained-Release Coatings |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Delayed-Release (Enteric) Coatings |
| 6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Taste-Masking Coatings |
| 6.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Moisture Barrier Coatings |
| 6.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Others |
| 6.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 7.Global Tablet Coatings Market By End User, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 7.1. Pharmaceutical Industry |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Nutraceutical Industry |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Research Laboratories |
| 7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Contract Manufacturing Organizations (CMOs) |
| 7.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Others |
| 7.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.Global Tablet Coatings Market By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Tablet Coatings Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 9.1. Polymer Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Cellulosic Polymers |
| 9.1.2.Vinyl Derivatives |
| 9.1.3.Methacrylic Polymers |
| 9.1.4.Polyethylene Glycol (PEG) |
| 9.1.5.Others |
| 9.2. Functionality Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Immediate-Release Coatings |
| 9.2.2.Sustained-Release Coatings |
| 9.2.3.Delayed-Release (Enteric) Coatings |
| 9.2.4.Taste-Masking Coatings |
| 9.2.5.Moisture Barrier Coatings |
| 9.2.6.Others |
| 9.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Pharmaceutical Industry |
| 9.3.2.Nutraceutical Industry |
| 9.3.3.Research Laboratories |
| 9.3.4.Contract Manufacturing Organizations (CMOs) |
| 9.3.5.Others |
| 9.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Tablet Coatings Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 10.1. Polymer Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Cellulosic Polymers |
| 10.1.2.Vinyl Derivatives |
| 10.1.3.Methacrylic Polymers |
| 10.1.4.Polyethylene Glycol (PEG) |
| 10.1.5.Others |
| 10.2. Functionality Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Immediate-Release Coatings |
| 10.2.2.Sustained-Release Coatings |
| 10.2.3.Delayed-Release (Enteric) Coatings |
| 10.2.4.Taste-Masking Coatings |
| 10.2.5.Moisture Barrier Coatings |
| 10.2.6.Others |
| 10.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Pharmaceutical Industry |
| 10.3.2.Nutraceutical Industry |
| 10.3.3.Research Laboratories |
| 10.3.4.Contract Manufacturing Organizations (CMOs) |
| 10.3.5.Others |
| 10.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 11.Asia Pacific (APAC) Tablet Coatings Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 11.1. Polymer Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Cellulosic Polymers |
| 11.1.2.Vinyl Derivatives |
| 11.1.3.Methacrylic Polymers |
| 11.1.4.Polyethylene Glycol (PEG) |
| 11.1.5.Others |
| 11.2. Functionality Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Immediate-Release Coatings |
| 11.2.2.Sustained-Release Coatings |
| 11.2.3.Delayed-Release (Enteric) Coatings |
| 11.2.4.Taste-Masking Coatings |
| 11.2.5.Moisture Barrier Coatings |
| 11.2.6.Others |
| 11.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Pharmaceutical Industry |
| 11.3.2.Nutraceutical Industry |
| 11.3.3.Research Laboratories |
| 11.3.4.Contract Manufacturing Organizations (CMOs) |
| 11.3.5.Others |
| 11.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Tablet Coatings Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 12.1. Polymer Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Cellulosic Polymers |
| 12.1.2.Vinyl Derivatives |
| 12.1.3.Methacrylic Polymers |
| 12.1.4.Polyethylene Glycol (PEG) |
| 12.1.5.Others |
| 12.2. Functionality Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Immediate-Release Coatings |
| 12.2.2.Sustained-Release Coatings |
| 12.2.3.Delayed-Release (Enteric) Coatings |
| 12.2.4.Taste-Masking Coatings |
| 12.2.5.Moisture Barrier Coatings |
| 12.2.6.Others |
| 12.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Pharmaceutical Industry |
| 12.3.2.Nutraceutical Industry |
| 12.3.3.Research Laboratories |
| 12.3.4.Contract Manufacturing Organizations (CMOs) |
| 12.3.5.Others |
| 12.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Tablet Coatings Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 13.1. Polymer Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Cellulosic Polymers |
| 13.1.2.Vinyl Derivatives |
| 13.1.3.Methacrylic Polymers |
| 13.1.4.Polyethylene Glycol (PEG) |
| 13.1.5.Others |
| 13.2. Functionality Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Immediate-Release Coatings |
| 13.2.2.Sustained-Release Coatings |
| 13.2.3.Delayed-Release (Enteric) Coatings |
| 13.2.4.Taste-Masking Coatings |
| 13.2.5.Moisture Barrier Coatings |
| 13.2.6.Others |
| 13.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Pharmaceutical Industry |
| 13.3.2.Nutraceutical Industry |
| 13.3.3.Research Laboratories |
| 13.3.4.Contract Manufacturing Organizations (CMOs) |
| 13.3.5.Others |
| 13.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Colorcon Inc. |
| 14.2.2.Ashland Global Holdings, Inc. |
| 14.2.3.Evonik Industries AG |
| 14.2.4.BASF SE |
| 14.2.5.Roquette Frères |
| 14.2.6.Sensient Technologies Corporation |
| 14.2.7.Merck KGaA |
| 14.2.8.Corel Pharma Chem |
| 14.2.9.Ideal Cures Pvt. Ltd. |
| 14.2.10.DuPont de Nemours, Inc. |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Sample
